[{"id":"9b8f0668-89c2-4a17-b398-80a6f02ea55e","acronym":"","url":"https://clinicaltrials.gov/study/NCT01865045","created_at":"2021-01-18T08:20:35.723Z","updated_at":"2024-07-02T16:36:04.175Z","phase":"","brief_title":"Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients","source_id_and_acronym":"NCT01865045","lead_sponsor":"Armando Santoro, MD","biomarkers":" BRCA1 • TUBB3","pipe":" | ","alterations":" BRCA1 expression • TUBB3 expression","tags":["BRCA1 • TUBB3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRCA1 expression • TUBB3 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e vinorelbine tartrate"],"overall_status":"Completed","enrollment":" Enrollment 150","initiation":"Initiation: 11/01/2012","start_date":" 11/01/2012","primary_txt":" Primary completion: 12/01/2016","primary_completion_date":" 12/01/2016","study_txt":" Completion: 12/01/2017","study_completion_date":" 12/01/2017","last_update_posted":"2022-09-10"},{"id":"665a24f0-30ae-47ae-bd4a-55761e74693b","acronym":"","url":"https://clinicaltrials.gov/study/NCT02948075","created_at":"2021-01-18T14:28:35.503Z","updated_at":"2024-07-02T16:37:09.434Z","phase":"Phase 2","brief_title":"Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy","source_id_and_acronym":"NCT02948075","lead_sponsor":"NewVac LLC","biomarkers":" BRCA1 • ERCC1 • CDH1","pipe":" | ","alterations":" BRCA1 expression • CDH1 expression • ERCC1 expression","tags":["BRCA1 • ERCC1 • CDH1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRCA1 expression • CDH1 expression • ERCC1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e carboplatin • paclitaxel • quisinostat (JNJ 26481585)"],"overall_status":"Completed","enrollment":" Enrollment 31","initiation":"Initiation: 09/01/2015","start_date":" 09/01/2015","primary_txt":" Primary completion: 12/01/2016","primary_completion_date":" 12/01/2016","study_txt":" Completion: 06/16/2017","study_completion_date":" 06/16/2017","last_update_posted":"2018-06-27"},{"id":"43e10b1a-f6dd-4102-b559-116081ca41ce","acronym":"","url":"https://clinicaltrials.gov/study/NCT02940132","created_at":"2021-01-17T17:55:31.388Z","updated_at":"2024-07-02T16:37:15.762Z","phase":"Phase 1","brief_title":"A Study of SC10914 in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT02940132","lead_sponsor":"Jiangxi Qingfeng Pharmaceutical Co. Ltd.","biomarkers":" BRCA1 • BRCA2 • ATM","pipe":" | ","alterations":" BRCA2 mutation • BRCA1 mutation • BRCA1 expression • ATM expression","tags":["BRCA1 • BRCA2 • ATM"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRCA2 mutation • BRCA1 mutation • BRCA1 expression • ATM expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SC10914"],"overall_status":"Unknown status","enrollment":" Enrollment 72","initiation":"Initiation: 10/01/2016","start_date":" 10/01/2016","primary_txt":" Primary completion: 03/01/2018","primary_completion_date":" 03/01/2018","study_txt":" Completion: 05/01/2018","study_completion_date":" 05/01/2018","last_update_posted":"2017-12-06"},{"id":"be5e275a-d3c3-4cc3-a77f-fc3270d3831d","acronym":"BERNAQ","url":"https://clinicaltrials.gov/study/NCT02365805","created_at":"2021-01-18T11:15:56.878Z","updated_at":"2024-07-02T16:37:24.490Z","phase":"Phase 2","brief_title":"Randomized CT to Evaluate Efficacy of Neoadjuvant Chemotherapy Customized by Levels of BRCA1-HER2 Negative Breast Cancer","source_id_and_acronym":"NCT02365805 - BERNAQ","lead_sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","biomarkers":" HER-2 • PGR • BRCA1","pipe":" | ","alterations":" HER-2 negative • PGR positive • BRCA1 expression","tags":["HER-2 • PGR • BRCA1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative • PGR positive • BRCA1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • paclitaxel • docetaxel • 5-fluorouracil • epirubicin"],"overall_status":"Completed","enrollment":" Enrollment 30","initiation":"Initiation: 04/01/2014","start_date":" 04/01/2014","primary_txt":" Primary completion: 10/10/2016","primary_completion_date":" 10/10/2016","study_txt":" Completion: 10/10/2016","study_completion_date":" 10/10/2016","last_update_posted":"2017-03-13"}]